Topical use of Eucalypt sap resin for damaged skin
Safety and efficacy of Eucalypt sap resin for inflammatory skin conditions and wound care in adults – An exploratory case series
Integria Healthcare (Australia) Pty Ltd.
60 participants
Apr 24, 2024
Interventional
Conditions
Summary
This protocol aims to explore the potential effectiveness of topical eucalypt sap resin application across a range of both acute and chronic skin injury and inflammatory conditions, using this novel Australian native ingredient with antimicrobial, styptic, and astringent properties. Skin conditions to be evaluated as individual case studies under this protocol cover wound care (both acute and chronic), fungal skin infections, acne, insect bites and sunburn.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Arm A - Eucalypt extract (C5-2024) in inert gel formulation The treatment will be individualised as appropriate for each case and documented as individual case studies. The gel will be applied topically to affected skin area at a dose of 1mL per cm2. For all wound presentations, the product will be applied by a wound care nurse in a medical clinic, in accordance with standard wound management guidelines appropriate for the type of wound, i.e. application and re-dressing every 7 days or as required. For all other conditions, the product will be applied by the participant themselves in their home environment. Adherence and overall usage of test product will be checked by monitoring of remaining gel amounts.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12624000276550